128 related articles for article (PubMed ID: 15156160)
1. Glial cell expression of hepatocyte growth factor in vitreoretinal proliferative disease.
Hollborn M; Krausse C; Iandiev I; Yafai Y; Tenckhoff S; Bigl M; Schnurrbusch UE; Limb GA; Reichenbach A; Kohen L; Wolf S; Wiedemann P; Bringmann A
Lab Invest; 2004 Aug; 84(8):963-72. PubMed ID: 15156160
[TBL] [Abstract][Full Text] [Related]
2. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
[TBL] [Abstract][Full Text] [Related]
3. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
Briggs MC; Grierson I; Hiscott P; Hunt JA
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy.
Lashkari K; Rahimi N; Kazlauskas A
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):149-56. PubMed ID: 9888438
[TBL] [Abstract][Full Text] [Related]
5. Expression of HB-EGF by retinal pigment epithelial cells in vitreoretinal proliferative disease.
Hollborn M; Iandiev I; Seifert M; Schnurrbusch UE; Wolf S; Wiedemann P; Bringmann A; Kohen L
Curr Eye Res; 2006 Oct; 31(10):863-74. PubMed ID: 17050278
[TBL] [Abstract][Full Text] [Related]
6. Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy.
Cui JZ; Chiu A; Maberley D; Ma P; Samad A; Matsubara JA
Eye (Lond); 2007 Feb; 21(2):200-8. PubMed ID: 16531976
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
[TBL] [Abstract][Full Text] [Related]
8. Basic fibroblast growth factor mRNA, bFGF peptide and FGF receptor in epiretinal membranes of intraocular proliferative disorders (PVR and PDR).
Hueber A; Wiedemann P; Esser P; Heimann K
Int Ophthalmol; 1996-1997; 20(6):345-50. PubMed ID: 9237137
[TBL] [Abstract][Full Text] [Related]
9. Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study.
Simó R; Vidal MT; García-Arumí J; Carrasco E; García-Ramírez M; Segura RM; Hernández C
Diabetes Res Clin Pract; 2006 Jan; 71(1):36-44. PubMed ID: 16029908
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the basic fibroblast growth factor-evoked proliferation of the human Müller cell line, MIO-M1.
Hollborn M; Jahn K; Limb GA; Kohen L; Wiedemann P; Bringmann A
Graefes Arch Clin Exp Ophthalmol; 2004 May; 242(5):414-22. PubMed ID: 14963717
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
[TBL] [Abstract][Full Text] [Related]
12. Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation.
Umeda N; Ozaki H; Hayashi H; Kondo H; Uchida H; Oshima K
Ophthalmic Res; 2002; 34(1):43-7. PubMed ID: 11834884
[TBL] [Abstract][Full Text] [Related]
13. HGF regulation of RPE proliferation in an IL-1beta/retinal hole-induced rabbit model of PVR.
Liou GI; Pakalnis VA; Matragoon S; Samuel S; Behzadian MA; Baker J; Khalil IE; Roon P; Caldwell RB; Hunt RC; Marcus DM
Mol Vis; 2002 Dec; 8():494-501. PubMed ID: 12500176
[TBL] [Abstract][Full Text] [Related]
14. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.
Harada C; Harada T; Mitamura Y; Quah HM; Ohtsuka K; Kotake S; Ohno S; Wada K; Takeuchi S; Tanaka K
Mol Vis; 2004 Jan; 10():31-6. PubMed ID: 14737065
[TBL] [Abstract][Full Text] [Related]
15. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy.
Mori K; Gehlbach P; Ando A; Dyer G; Lipinsky E; Chaudhry AG; Hackett SF; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2001-6. PubMed ID: 12037011
[TBL] [Abstract][Full Text] [Related]
16. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
[TBL] [Abstract][Full Text] [Related]
18. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration.
Oberstein SY; Byun J; Herrera D; Chapin EA; Fisher SK; Lewis GP
Mol Vis; 2011; 17():1794-805. PubMed ID: 21750605
[TBL] [Abstract][Full Text] [Related]
19. Rabbit retinal Müller cells undergo antigenic changes in response to experimentally induced proliferative vitreoretinopathy.
McGillem GS; Dacheux RF
Exp Eye Res; 1999 May; 68(5):617-27. PubMed ID: 10328976
[TBL] [Abstract][Full Text] [Related]
20. Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina.
Goczalik I; Ulbricht E; Hollborn M; Raap M; Uhlmann S; Weick M; Pannicke T; Wiedemann P; Bringmann A; Reichenbach A; Francke M
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4578-89. PubMed ID: 18552386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
